BMS-199264
BMS-199264 is an inhibitor of F1F0 ATP hydrolase (IC50=0.5 μM) without inhibitory effect on F1F0 ATP synthase. BMS-199264 selectively inhibits ATP decline during ischemia to reduces cardiac necrosis. BMS-199264 also enhances the recovery of contractile function following reperfusion[1].
Product Specifications
CAS Number
675833-20-2
UNSPSC
12352005
Target
ATP Synthase
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O[C@@H]1C(C)(OC2=CC=C(C=C2[C@H]1N(CC3=NC=CN3)C4=CC=C(C=C4)Cl)S(=O)(N5CCCCC5)=O)C
Molecular Formula
C26H31ClN4O4S
Molecular Weight
531.07
References & Citations
[1]Grover GJ, et al. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Cardiovasc Ther. 2008 Winter;26 (4) :287-96.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
18908061 1.0 µg DNA
EDC3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details ![Rabbit Polyclonal NUB1/NYREN18 Antibody [Alexa Fluor 488]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-97440AF488 0.1 mL
Rabbit Polyclonal NUB1/NYREN18 Antibody [Alexa Fluor 488]
Sign In for Pricing
View Details ![Rabbit Polyclonal HLCS Antibody [DyLight 488]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
K6583008 1.0 µg DNA
Klk8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details